Browse hierarchy: [Clinical Chemistry (CH)](/submissions/CH) → [Subpart B — Clinical Chemistry Test Systems](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems) → [21 CFR 862.1445](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/862.1445) → JGF — Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes

# JGF · Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes

_Clinical Chemistry · 21 CFR 862.1445 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF

## Overview

- **Product Code:** JGF
- **Device Name:** Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes
- **Regulation:** [21 CFR 862.1445](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/862.1445)
- **Device Class:** 2
- **Review Panel:** [Clinical Chemistry](/submissions/CH)

## Identification

A lactate dehydrogenase isoenzymes test system is a device intended to measure the activity of lactate dehydrogenase isoenzymes (a group of enzymes with similar biological activity) in serum. Measurements of lactate dehydrogenase isoenzymes are used in the diagnosis and treatment of liver diseases, such as viral hepatitis, and myocardial infarction.

## Classification Rationale

Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Recent Cleared Devices (6 of 6)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K981338](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF/K981338.md) | LD-1 | Abbott Laboratories | May 18, 1998 | SESE |
| [K925188](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF/K925188.md) | ABBOTT QUICKSTART LD-1, MODIFICATION | Em Diagnostic Systems, Inc. | Feb 5, 1993 | SESE |
| [K914261](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF/K914261.md) | ABBOTT QUICKSTART LD-1,#5A30 | Em Diagnostic Systems, Inc. | Oct 21, 1991 | SESE |
| [K890996](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF/K890996.md) | LD1 ISOENZYME REAGENT KIT | Trace Scientific , Ltd. | May 5, 1989 | SESE |
| [K871240](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF/K871240.md) | ABBOTT A-GENT LD-1 ISOZYME REAGENT | Abbott Laboratories | May 13, 1987 | SESE |
| [K860367](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF/K860367.md) | MAGNESIUM (SUBSTRATE, ENZYME, REAGENT) | Alpkem Corp. | Apr 11, 1986 | SESE |

## Top Applicants

- Abbott Laboratories — 2 clearances
- Em Diagnostic Systems, Inc. — 2 clearances
- Alpkem Corp. — 1 clearance
- Trace Scientific , Ltd. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JGF)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com